All Companies
LLY
Eli Lilly & Co.Pharmaceutical Preparations
$1,152.93updated Sep 19, 2026
Congressional trading profile for Eli Lilly & Co. (LLY), covering 53 disclosed transactions by 22 lawmakers.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Total Trades
53
Politicians Trading
22
Last Traded
Jul 10, 2026
Price history
Congressional Trades
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Ron WydenD | Feb 21, 2025 | Jan 22, 2025 | Buy | $50,001 - $100,000 | +52.91% |
| Josh GottheimerD | Feb 10, 2025 | Jan 8, 2025 | Sell | $1,001 - $15,000 | +46.46% |
| Marjorie Taylor GreeneR | Jan 27, 2025 | Jan 21, 2025 | Buy | $1,001 - $15,000 | +55.31% |
Page 2 of 2